Colposcopy: The value of HPV testing in clinical practice;Colposcopie: Apport du test HPV en pratique clinique

Gynecologie Obstetrique et Fertilite

Volumn 32, Issue 1, 2004, Pages 62-74

  Monsonego, J ^a  

^a INSTITUT ALFRED FOURNIER   (France)

Author keywords

ASC US; CIN; Colposcopy; HPV testing; Human Papillomavirus; Pap Test; SIL

Indexed keywords

VIRUS DNA;

ADENOCARCINOMA; CANCER HORMONE THERAPY; CANCER INVASION; CANCER SURGERY; CLINICAL PRACTICE; CLINICAL TRIAL; COLPOSCOPY; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; PRACTICE GUIDELINE; REVIEW; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; WART VIRUS;

EID: 0842303357     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2003.10.025     Document Type: Article

References (62)

1. Solomon D, Davey D, Kuman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. Jama 2002;287:2114-9.
2. Walkert P, Dexeus S, De Palo G, Barrasso R, Campion M, Girardi F, Jacob C, Roy M. Internationale terminology of colposcopy: An updated report from the internationale federation for cervical pathology and colposcopy. Obst Gyn 2003;101:175-7.
3. Mitchell MF, Schottenfeld D, Tortolero-Luna G, Cantor SB, Richards-Kortum R. Colposcopy for the diagnosis of squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;91:626-31.
4. Kirby AJ, Spiegelhalter DJ, Day NE, Fenton L, Swanson K, Mann EM, Macgregor JE. Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet 1992;339:828-31.
5. Raffle AE. Invasive cervical cancer after treatment of cervical intraepithelial neoplasia. Lancet 1997;349(9069):1910.
6. Hopman EH, Voorhorst FJ, Kenemans P, Meyer CJ, Helmerhorst TJ. Observer agreement on interpreting colposcopic images of CIN. Gynecol Oncol 1995;58:206-9.
7. Sellors JW, Niewinen P, Vesterinen E, Paavonen J. Observer variability in the scoring of colpophotographs. Obstet Gynecol 1990;76:1006-8.
8. Solomon D, Schiffman M, Tarrone R. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance. J Natl Cancer Inst 2001;93:293-9.
9. Higgins RV, Hall JB, McGee JA, Laurent S, Alvarez RD, Partridge EE. Appraisal of the modalities used to evaluate an initial abnormal Papanicolaou smear. Obstet Gynecol 1994;84:174-8.
10. Baldauf JJ, Dreyfus M, Ritter J, Philippe E. An analysis of the factors involved in the diagnostic accuracy of colposcopically directed biopsy. Actu Obstet Gynecol Scand 1997;76:468-73.
11. Stoler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations. JAMA 2001;285:1500-5.
12. Agence nationale d'accréditation et d'évaluation en santé (Anaes). Conduite à tenir devant un frottis anormal du col de l'utérus. Recommandations pour la pratique clinique, actualisation, 2002.
13. Wright TC, Cox TJ, Massad SL, Twiggs LB, Wilkinson EJ. Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002;287:2120-9 2001.
14. Monsonego J, Autillo-Touati A, Bergeron C, Dachez R, Liaras J, Saurel J, et al. Liquid based cytology for primary cervical cancer screening: a multi-centre study. British Journal of cancer 2001;84(3):360-6.
15. Lonky NM, Sadeghi M, Tsadik GW, Petitti D. The clinical significance of the poor correlation of cervical dysplasia and cervical malignancy with referral cytologic results. AM J Obstet Gynecol 1999;181:560-6.
16. Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, et al. Identifying women with cervical neoplasia: using human Papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-10.
17. Cox JT, Wilkinson EJ, Lonky N, Wawman A, Tosh R, Tedeschi C. Management guidelines for the follow-up of atypical squamous cells of undetermined significance (ASC-US). J Lower Gen Tract Dis 2000;4:99-105.
18. Cox T, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human Papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
19. Ferris DG, Wright Jr TC, Litaker MS, Richart RM, Lorincz AT, Sun XW, Borgatta L, Buck H, Kramer L, Rubin R. Triage of women with ASC-US and LSIL on Pap smear reports: management by repeat Pap smear, HPV DNA testing, or colposcopy? J Fam Pract 1998;46:125-34.
20. Kim JJ, Wright TC, Goldie S. Cost effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002;287(18):2382-90.
21. ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomised trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188(6):1383-92.
22. Solomon D. Role of triage testing in cervical cancer screening. J Natl Cancer Inst Monogr 2003;31:97-101.
23. Monsonego J. Cervical cancer screening and prevention. New directions and priorities. Int J Cancer 2003;108 Accepté pour publication.
24. Sherman ME, Solomon D, Schiffman M. Qualification of ASC-US: a comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASC-US LSIL Triage Study (ALTS). Am J Clin Pathol 2001;117(1):96-102.
25. Ronnett BM, Manos MM, Ransley JE, Fetterman BJ, Kinney WK, Hurley LB, et al. Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results and human Papillomavirus DNA detection. Hum Pathol 1999;30:816-25.
26. Eddy GL, Wojtowycz MA, Piraino PS, Mazur MT. Papanicolaou smears by the Bethesda system in endometrial malignancy. Obstet Gynecol 1997;90:999-1003.
27. Duska LR, Flynn CF, Chen A, Whall-Strojwas D, Goodman A. Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet Gynecol 1998;91:278-82.
28. Jones BA, Novis DA. Follow-up of abnormal gynecologic cytology: a college of American pathologists Q-probes study of 16,132 cases from 306 laboratories. Arch Pathol Lab Med 2000;124:665-71.
29. Chieng DC, Elgert P, Cohen JM, Cangiarella JF. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women. Cancer 2001;93:1-7.
30. Laverty CR, Famsworth A, Thurloe J, Bowditch R. The reliability of a cytological prediction of cervical adenocarcinoma in situ. Aust N Z J Obstet Gynecol 1988;28:307-12.
31. Lee KR, Manna EA, St John T. Atypical endocervical glandular cells: accuracy of cytologic diagnosis. Diagn cytopathol 1995;13:202-8.
32. Cullimore JE, Luesley DM, Rollason TP, Byrne P, Buckley CH, Anderson M, Williams DR, Waddell C, Hudson E, Shafi MI. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN) - a preliminary report. Br J Obstet Gynecol 1992;99:314-8.
33. Kim TJ, Kim HS, Park CT, Park IS, Hong SR, Park JS, et al. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears. Gynecol Oncol 1999;73:292-8.
34. Ostor AG, Duncan A, Quinn M, Rome R. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol Oncol 2000;79:207-10.
35. Muntz HG, Bell DA, Lage JM, Goff BA, Feldman S, Rice LW. Adenocarcinoma in situ of the uterine cervix. Obstet Gynecol 1992;80:935-9.
36. Robertson JH, Woodend BE, Elliott H. Cytological changes preceding cervical cancer. J Clin Pathol 1994;47:278-9.
37. Robertson JH, Woodend BR, Crozier EH, Hutchinson J. Risk of cervical cancer associated with mild dyskaryosis. BMJ 1988;297:18-21.
38. Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (Alts) Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions. J Natl Cancer Inst 2000;92:397-402.
39. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? Obstet Gynecol 1998;91:973-6.
40. Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol 2001;82:516-22.
41. Limay A, Connor Amsy J, Huang X, Luff R. Comparative analysis of conventional Papanicolaou tests ans a fluid-based thin-layer method. Arch Pathol Lab Med 2003;127:200-4.
42. Yeoh GPS, Chan KW, Lauder I, Lam MB. Evaluation of the Thin Prep Papanicolaou test in clinical practice: 6-month study of 16,541 cases with histological correlation in 220 cases. Hong Kong Med J 1999;5:233-9.
43. Diaz-Rosario L, Kabawat S. Performance of a fluid-based, thin-layer Papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England. Arch Pathol Lab Med 1999;123:817-21.
44. Hutchinson ML, Zahniser DJ, Sherman ME, et al. Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma. Cancer (Cancer Cytopathol) 1999;87:48-55.
45. Coste J, Cochanot-Priollet B, De Cremoux P, Le Gales P, Cartier I, Molinie V, Labbe S, Vacher Lavenu MC, Vielh P. Cross sectional study of conventional cervical smear, monolayer cytology and human Papillomavirus DNA testing for cervical cancer screening. BMJ 2003;326:733-7.
46. Davey D, Austin M, Birdsong G, et al. ASCCP patient management guidelines pap test specimen adequacy and quality indicators. J Lower genital tract disease 2002;6(3):195-9.
47. Clavel C, Masure M, Bory JP, Putaud I, Mangeonjean C, Lorenzato M, et al. Human Papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7 932 women. Br J Cancer 2001;89:1616-23.
48. Lörincz AT, Richart RM. Human Papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 2003;127:959-68.
49. Dalstein V, Riethmuller D, Prejet JL, Lebail Carval K, Sautiere JL, Kantelip B, et al. Persistence and load of high risk HPV are predictors for development of high grade cervical lesions. Int J Cancer 2003;106(3):396-403.
50. Lorincz AT, Castle PE, Sherman ME, Scott DR, Glass AG, Wacholder S, et al. Viral load of human Papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002;360(9328):228-9.
51. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16 (INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001;92:276-84.
52. Kjellberg L, Wiklund F, Sjöberg I, Wadell G, Angstrom T, Dillner J, et al. A population based study of human papillomavirus deoxyribonucleic acid testing for predicting cervical intra-epithelial neoplasia. Am J Obstet Gynecol 1998;179:1497-502.
53. Shlay JC, Dunn T, Byers T, Baron AE, Douglas Jr JM. Prediction of cervical intraepithelial neoplasia grade 2-3 using risk assessment and human papillomavirus testing in women with atypia on papanicolaou smears. Obstet Gynecol 2000;96:410-6.
54. Belinson J, Qiao YL, Pretorius R, Zhang WH, Elson P, Li L, et al. Shanxi Province cervical cancer screening study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol 2001;83:439-44.
55. Cox JT, Schiffman M, Solomon D. Prospective follow-up suggest similar risk of subsequent cervical intraepithelial neoplasia grade 2 or 3 among women with cervical intraepithelial neoplasia grade 1 or negative colposcopy and directed biopsy. Am J Obstet Gynecol 2003;188(6):1406-12.
56. Guido R, Schiffman M, Solomon D, Burke L. Postcolposcopy management strategies for women referred low-grade squamous intraepithelial lesions or human papillomavirus DANN-positive atypical squamous cells of undetermined significance: a two-year prospective study. Am J Obstet Gynecol 2003;188(6):1401-5.
57. Wright TC, Cox TJ, Massad SL, Jay C, Twiggs LB, Wilkinson EJ. 2201. Consensus Guidelines for the management of woman with cervical intraepithelial neoplasia. Am J Obstet Gyneco 2003;189:295-304.
58. Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, et al. Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 1999;354:20-5.
59. Paraskevaidis E, Jandial L, Mann EMF, Fisher PM, Kitchener HC. Pattern of treatment failure following laser for cervical intraepithelial neoplasia: implications for follow-up protocol. Obstet Gynecol 1991;78:80-3.
60. Monsonego J. Multicentric intra-epithelial neoplasia. Journ. of reproductive medecine. 2003. J Clin Pathol 1998;43(7):609-10.
61. Monsonego J, Zerat L, Catalan F, Coscas Y. Genital human Papillomavirus infections: correlation of cytological, colposcopic and histological features with viral types in women and their partners. Int J STD AIDS 1993;4(1):13-20.
62. Monsonego J. Spontaneous screening: benefits and limitations. In: Franco E, Monsonego J, editors. New Development in Cervical Cancer Screening and Prevention. Oxford: Blackwell Science; 1997. p. 220-40.